189 related articles for article (PubMed ID: 35314669)
21. The ratio of transforming growth factor-β1/bone morphogenetic protein-7 in the progression of the epithelial-mesenchymal transition contributes to rat liver fibrosis.
Bi WR; Xu GT; Lv LX; Yang CQ
Genet Mol Res; 2014 Feb; 13(1):1005-14. PubMed ID: 24634122
[TBL] [Abstract][Full Text] [Related]
22. NDRG2 knockdown promotes fibrosis in renal tubular epithelial cells through TGF-β1/Smad3 pathway.
Jin Z; Gu C; Tian F; Jia Z; Yang J
Cell Tissue Res; 2017 Sep; 369(3):603-610. PubMed ID: 28646304
[TBL] [Abstract][Full Text] [Related]
23. MAD2B-mediated SnoN downregulation is implicated in fibroblast activation and tubulointerstitial fibrosis.
Tang H; Su H; Fan D; Ye C; Lei CT; Jiang HJ; Gao P; He FF; Zhang C
Am J Physiol Renal Physiol; 2016 Jul; 311(1):F207-16. PubMed ID: 27122545
[TBL] [Abstract][Full Text] [Related]
24. Novel RAS inhibitor 25-O-methylalisol F attenuates epithelial-to-mesenchymal transition and tubulo-interstitial fibrosis by selectively inhibiting TGF-β-mediated Smad3 phosphorylation.
Chen H; Yang T; Wang MC; Chen DQ; Yang Y; Zhao YY
Phytomedicine; 2018 Mar; 42():207-218. PubMed ID: 29655688
[TBL] [Abstract][Full Text] [Related]
25. Beta-casomorphin-7 prevents epithelial-mesenchymal transdifferentiation of NRK-52E cells at high glucose level: Involvement of AngII-TGF-β1 pathway.
Zhang W; Song S; Liu F; Liu Y; Zhang Y
Peptides; 2015 Aug; 70():37-44. PubMed ID: 25882007
[TBL] [Abstract][Full Text] [Related]
26. Transforming growth factor-β1 suppresses bone morphogenetic protein-2-induced mesenchymal-epithelial transition in HSC-4 human oral squamous cell carcinoma cells via Smad1/5/9 pathway suppression.
Chiba T; Ishisaki A; Kyakumoto S; Shibata T; Yamada H; Kamo M
Oncol Rep; 2017 Feb; 37(2):713-720. PubMed ID: 28035402
[TBL] [Abstract][Full Text] [Related]
27. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition in human renal proximal tubular epithelial cells.
Xu Y; Wan J; Jiang D; Wu X
J Nephrol; 2009; 22(3):403-10. PubMed ID: 19557718
[TBL] [Abstract][Full Text] [Related]
28. Blood glucose control contributes to protein stability of Ski-related novel protein N in a rat model of diabetes.
Liang L; Li S; Liu H; Mao Y; Liu L; Zhang X; Peng W; Xiao Y; Zhang F; Shi M; Wang Y; Guo B
Exp Ther Med; 2021 Nov; 22(5):1341. PubMed ID: 34630695
[TBL] [Abstract][Full Text] [Related]
29. A bioinformatics and network pharmacology approach to the mechanisms of action of Shenxiao decoction for the treatment of diabetic nephropathy.
Mou X; Zhou DY; Zhou D; Liu K; Chen LJ; Liu WH
Phytomedicine; 2020 Apr; 69():153192. PubMed ID: 32200292
[TBL] [Abstract][Full Text] [Related]
30. Quercetin inhibits the mTORC1/p70S6K signaling-mediated renal tubular epithelial-mesenchymal transition and renal fibrosis in diabetic nephropathy.
Lu Q; Ji XJ; Zhou YX; Yao XQ; Liu YQ; Zhang F; Yin XX
Pharmacol Res; 2015 Sep; 99():237-47. PubMed ID: 26151815
[TBL] [Abstract][Full Text] [Related]
31. Quercetin inhibits kidney fibrosis and the epithelial to mesenchymal transition of the renal tubular system involving suppression of the Sonic Hedgehog signaling pathway.
Liu X; Sun N; Mo N; Lu S; Song E; Ren C; Li Z
Food Funct; 2019 Jun; 10(6):3782-3797. PubMed ID: 31180394
[TBL] [Abstract][Full Text] [Related]
32. [Effects of bone morphogenic protein-7 on transdifferentiation and the expression of connective tissue growth factor of human renal tubular epithelial cells induced by transforming growth factor-beta1].
Xu YF; Wan JX; Jiang DW
Zhonghua Yi Xue Za Zhi; 2009 Jun; 89(23):1639-44. PubMed ID: 19957515
[TBL] [Abstract][Full Text] [Related]
33. FoxO1-mediated inhibition of STAT1 alleviates tubulointerstitial fibrosis and tubule apoptosis in diabetic kidney disease.
Huang F; Wang Q; Guo F; Zhao Y; Ji L; An T; Song Y; Liu Y; He Y; Qin G
EBioMedicine; 2019 Oct; 48():491-504. PubMed ID: 31629675
[TBL] [Abstract][Full Text] [Related]
34. Effects of ZnT8 on epithelial-to-mesenchymal transition and tubulointerstitial fibrosis in diabetic kidney disease.
Zhang X; Guan T; Yang B; Gu HF; Chi Z
Cell Death Dis; 2020 Jul; 11(7):544. PubMed ID: 32681069
[TBL] [Abstract][Full Text] [Related]
35. BMP-7 counteracts TGF-beta1-induced epithelial-to-mesenchymal transition and reverses chronic renal injury.
Zeisberg M; Hanai J; Sugimoto H; Mammoto T; Charytan D; Strutz F; Kalluri R
Nat Med; 2003 Jul; 9(7):964-8. PubMed ID: 12808448
[TBL] [Abstract][Full Text] [Related]
36. Bone morphogenetic protein-7 inhibits proximal tubular epithelial cell Smad3 signaling via increased SnoN expression.
Luo DD; Phillips A; Fraser D
Am J Pathol; 2010 Mar; 176(3):1139-47. PubMed ID: 20093492
[TBL] [Abstract][Full Text] [Related]
37. Membrane rafts-redox signalling pathway contributes to renal fibrosis via modulation of the renal tubular epithelial-mesenchymal transition.
Han WQ; Xu L; Tang XF; Chen WD; Wu YJ; Gao PJ
J Physiol; 2018 Aug; 596(16):3603-3616. PubMed ID: 29863758
[TBL] [Abstract][Full Text] [Related]
38. Resveratrol inhibits epithelial-mesenchymal transition and renal fibrosis by antagonizing the hedgehog signaling pathway.
Bai Y; Lu H; Wu C; Liang Y; Wang S; Lin C; Chen B; Xia P
Biochem Pharmacol; 2014 Dec; 92(3):484-93. PubMed ID: 25219324
[TBL] [Abstract][Full Text] [Related]
39. Schisandrin B Alleviates Renal Tubular Cell Epithelial-Mesenchymal Transition and Mitochondrial Dysfunction by Kielin/Chordin-like Protein Upregulation via Akt Pathway Inactivation and Adenosine 5'-Monophosphate (AMP)-Activated Protein Kinase Pathway Activation in Diabetic Kidney Disease.
Liu W; Li F; Guo D; Du C; Zhao S; Li J; Yan Z; Hao J
Molecules; 2023 Nov; 28(23):. PubMed ID: 38067580
[TBL] [Abstract][Full Text] [Related]
40. CRTC2 activates the epithelial-mesenchymal transition of diabetic kidney disease through the CREB-Smad2/3 pathway.
Li Y; Zhang Y; Shi H; Liu X; Li Z; Zhang J; Wang X; Wang W; Tong X
Mol Med; 2023 Oct; 29(1):146. PubMed ID: 37884902
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]